Cargando…

Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma

BACKGROUND: High expression of Bmi-1, a key regulatory component of the polycomb repressive complex-1, has been associated with many solid and hematologic malignancies including esophageal squamous cell carcinoma. However, little is known about the role of Bmi-1 in esophageal adenocarcinoma. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choy, Bonnie, Bandla, Santhoshi, Xia, Yinglin, Tan, Dongfeng, Pennathur, Arjun, Luketich, James D, Godfrey, Tony E, Peters, Jeffrey H, Sun, Jun, Zhou, Zhongren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544684/ https://www.ncbi.nlm.nih.gov/pubmed/23078618 http://dx.doi.org/10.1186/1471-230X-12-146

Ejemplares similares

Cyclin E involved in early stage carcinogenesis of esophageal adenocarcinoma by SNP DNA microarray and immunohistochemical studies
por: Zhou, Zhongren, et al.
Publicado: (2014)

MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions(,)
por: Choy, Bonnie, et al.
Publicado: (2016)

Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma
por: Ji, Huaijun, et al.
Publicado: (2017)

The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis
por: Huang, Binhao, et al.
Publicado: (2021)

Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
por: Dulak, Austin M., et al.
Publicado: (2013)

Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences
por: Pang, Chunhong, et al.
Publicado: (2017)

Esophageal squamous papilloma lacks clear clinicopathological associations
por: Jideh, Bilel, et al.
Publicado: (2017)

High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7
por: Huber, Aaron R., et al.
Publicado: (2015)

Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer
por: Xi, Liqiang, et al.
Publicado: (2008)

PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
por: Rong, Lulu, et al.
Publicado: (2019)

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Clinicopathologic correlations of superficial esophageal adenocarcinoma in endoscopic submucosal dissection specimens
por: Dhingra, Sadhna, et al.
Publicado: (2021)

Clinicopathological Significance of BMP7 Expression in Esophageal Squamous Cell Carcinoma
por: Megumi, Koichi, et al.
Publicado: (2011)

Clinicopathological significance of deoxycytidine kinase expression in esophageal squamous cell carcinoma
por: SHIMADA, YUTAKA, et al.
Publicado: (2013)

Clinicopathologic analysis of lymph node status in superficial esophageal squamous carcinoma
por: Zhou, Yue, et al.
Publicado: (2016)

Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma
por: Wei, Meng Xia, et al.
Publicado: (2023)

Correlation of CD146 expression and clinicopathological characteristics in esophageal squamous cell carcinoma
por: LI, YAN, et al.
Publicado: (2014)

Clinicopathological significance of cystatin A expression in progression of esophageal squamous cell carcinoma
por: Shiba, Daiki, et al.
Publicado: (2018)

The Clinicopathological Correlations of hTERC Amplification with Esophageal Squamous Cell Precursor Lesions
por: Hu, Yanping, et al.
Publicado: (2018)

Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma
por: Muhetaer, Aishanjiang, et al.
Publicado: (2020)

Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy
por: Grageda, Mayen T, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma
por: Lei, Zhijin, et al.
Publicado: (2016)

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors
por: Jeong, Dong Young, et al.
Publicado: (2020)

Distribution of esophagus flora in esophageal squamous cell carcinoma and its correlation with clinicopathological characteristics
por: Hu, Mengcheng, et al.
Publicado: (2020)

Tumor Budding Is Associated with an Increased Risk of Lymph Node Metastasis and Poor Prognosis in Superficial Esophageal Adenocarcinoma
por: Landau, Michael S., et al.
Publicado: (2014)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
por: Li, Xianfeng, et al.
Publicado: (2023)

No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case–control study
por: Dura, Polat, et al.
Publicado: (2013)

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1
por: WANG, TING, et al.
Publicado: (2015)

Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo
por: Wang, Jiansong, et al.
Publicado: (2019)

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1
por: Wang, Ting, et al.
Publicado: (2023)

Clinicopathological Characteristics of Esophageal Squamous Papillomas in Japanese Patients—With Comparison of Findings from Western Countries
por: Takeshita, Kuniko, et al.
Publicado: (2006)

Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma
por: Xue, Li-Yan, et al.
Publicado: (2018)

Mitochondrial DNA deletions in patients with esophagitis, Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma
por: Keles, Muzaffer, et al.
Publicado: (2019)

Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma
por: Gockel, Ines, et al.
Publicado: (2006)

Simultaneous Esophageal Squamous Cell Carcinoma and Adenocarcinoma: A Case Report
por: Maleki, Iradj, et al.
Publicado: (2015)

Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma
por: Zhang, Guoqing, et al.
Publicado: (2019)

Global DNA methylation patterns in Barrett’s esophagus, dysplastic Barrett’s, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use
por: Kaz, Andrew M., et al.
Publicado: (2016)

Bmi1 Severs as a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma
por: Wang, Xiaochen, et al.
Publicado: (2020)

A comparative Analysis by SAGE of Gene Expression Profiles of Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma
por: van Baal, Jantine W. P. M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ah5er11spdepg7ov8k331h41sj